Evidence map›Paper›PMID 36033449›Full record

ArticleFrontiers in oncology2022

Development and validation of a deep learning model for breast lesion segmentation and characterization in multiparametric MRI.

Jingjin Zhu, Jiahui Geng, Wei Shan, Boya Zhang, Huaqing Shen, Xiaohan Dong, Mei Liu, Xiru Li, Liuquan Cheng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Cross-site Validation of AI Segmentation and Harmonization in Breast MRI.Journal of imaging informatics in medicine · 2025
    Article
  7. Review
  8. Clinical Application of Artificial Intelligence in Breast MRI.Journal of the Korean Society of Radiology · 2025
    Review
  9. Review
  10. AI Applications to Breast MRI: Today and Tomorrow.Journal of magnetic resonance imaging : JMRI · 2024
    Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingjin ZhuSchool of Medicine, Nankai University, Tianjin, China.
Jiahui GengDepartment of Neurology, Beijing Tiantan Hospital, Beijing, China.
Wei ShanDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Boya ZhangSchool of Medicine, Nankai University, Tianjin, China.
Huaqing ShenDepartment of Neurology, Beijing Tiantan Hospital, Beijing, China.
Xiaohan DongDepartment of Radiology, Chinese People's Liberation Army General Hospital, Beijing, China.
Mei LiuDepartment of Pathology, Chinese People's Liberation Army General Hospital, Beijing, China.
Xiru LiDepartment of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Liuquan ChengDepartment of Radiology, Chinese People's Liberation Army General Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: The utilization of artificial intelligence for the differentiation of benign and malignant breast lesions in multiparametric MRI (mpMRI) assists radiologists to improve diagnostic performance. Objectives: To develop an automated deep learning model for breast lesion segmentation and characterization and to evaluate the characterization performance of AI models and radiologists. Materials and methods: For lesion segmentation, 2,823 patients were used for the training, validation, and testing of the VNet-based segmentation models, and the average Dice similarity coefficient (DSC) between the manual segmentation by radiologists and the mask generated by VNet was calculated. For lesion characterization, 3,303 female patients with 3,607 pathologically confirmed lesions (2,213 malignant and 1,394 benign lesions) were used for the three ResNet-based characterization models (two single-input and one multi-input models). Histopathology was used as the diagnostic criterion standard to assess the characterization performance of the AI models and the BI-RADS categorized by the radiologists, in terms of sensitivity, specificity, accuracy, and the area under the receiver operating characteristic curve (AUC). An additional 123 patients with 136 lesions (81 malignant and 55 benign lesions) from another institution were available for external testing. Results: Of the 5,811 patients included in the study, the mean age was 46.14 (range 11-89) years. In the segmentation task, a DSC of 0.860 was obtained between the VNet-generated mask and manual segmentation by radiologists. In the characterization task, the AUCs of the multi-input and the other two single-input models were 0.927, 0.821, and 0.795, respectively. Compared to the single-input DWI or DCE model, the multi-input DCE and DWI model obtained a significant increase in sensitivity, specificity, and accuracy (0.831 vs. 0.772/0.776, 0.874 vs. 0.630/0.709, 0.846 vs. 0.721/0.752). Furthermore, the specificity of the multi-input model was higher than that of the radiologists, whether using BI-RADS category 3 or 4 as a cutoff point (0.874 vs. 0.404/0.841), and the accuracy was intermediate between the two assessment methods (0.846 vs. 0.773/0.882). For the external testing, the performance of the three models remained robust with AUCs of 0.812, 0.831, and 0.885, respectively. Conclusions: Combining DCE with DWI was superior to applying a single sequence for breast lesion characterization. The deep learning computer-aided diagnosis (CADx) model we developed significantly improved specificity and achieved comparable accuracy to the radiologists with promise for clinical application to provide preliminary diagnoses.

Indexed as

artificial intelligencebreastconvolutional neural networksdeep learningmagnetic resonance imaging

Identifiers

PMID36033449
PMCPMC9402900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.